• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
RBC Analyst Maintains Buy Rating and Target Price for ADC Therapeutics
12:31
Nov10
ADC Therapeutics SA released FY2025 9 Months Earnings on November 10 Pre-Market EST, Actual Revenue: USD 58.3 M, Actual EPS: USD -1.1583
14:30
ADC Therapeutics SA released FY2025 Q3 earnings on November 10 Pre-Market EST, actual revenue USD 16.43 M (forecast USD 16.79 M), actual EPS USD -0.3002 (forecast USD -0.3616)
14:30
Nov3
ADC Therapeutics SA to Release FY2025 Q3 Earnings on November 10, 2025 Pre-Market EST, Forecast Revenue USD 17.08 M, EPS USD -0.38
00:07
Oct13
ADC Therapeutics Unveils Expansion Plan for ZYNLONTA
11:54
Oct8
Schmidt Maintains Buy Rating on ADC Therapeutics Stock
11:02

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 16.43 M, Net Income -40.97 M, EPS -0.3002

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 18.84 M, Net Income -56.65 M, EPS -0.498

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 23.03 M, Net Income -38.6 M, EPS -0.36

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
456.090
+223.47%
+315.340
WHLR
5.380
+66.05%
+2.220
TGL
11.160
+65.14%
+4.402
TWNP
1.789
+56.89%
+0.658
TDIC
0.4150
+47.79%
+0.133
IRBT
4.230
+39.60%
+1.205
GFR.RT
1.180
+38.82%
+0.330
PRAX
260.500
+37.13%
+70.530
CLIK
7.660
+34.39%
+1.960
TORO
5.515
+33.54%
+1.385
View More